UTI Flexi Cap Fund

As of Jun 2026, UTI Flexi Cap Fund — an institution tracked through public shareholding filings — disclosed 15 holdings in Indian listed companies worth ₹15,804 crore. The same holdings-at-filing-value basis put it at ₹14,526 crore in Mar 2026 (+8.8%). Solomo carries these filings back to Mar 2021.

Largest disclosed positions in Jun 2026: Eternal Ltd (ETERNAL — 2.30% of the company, ₹6,257 crore); Info Edge (India) Ltd (NAUKRI — 2.56% of the company, ₹1,720 crore); Ajanta Pharma Ltd (AJANTPHARM — 3.11% of the company, ₹1,292 crore); Coforge Ltd (COFORGE — 1.95% of the company, ₹1,266 crore); Dixon Technologies (India) Ltd (DIXON — 1.52% of the company, ₹1,158 crore). Those 5 account for 74% of the disclosed value.

Changes in the Jun 2026 filings: Stake raised in Info Edge (India) Ltd (+0.23 pp), AAVAS Financiers Ltd (+0.16 pp), Eternal Ltd (+0.15 pp). Stake reduced in Coforge Ltd (−0.84 pp), ERIS Lifesciences Ltd (−0.34 pp), Sheela Foam Ltd (−0.31 pp). No longer disclosed after the previous quarter: Jubilant Foodworks Ltd, Dr Lal Pathlabs Ltd, Global Health Ltd, Indiamart Intermesh Ltd — which can mean a sale, a stake falling below the 1% disclosure line, or that name not filing this quarter.